UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6501
Pulse Biosciences
PLSE
$2.65B
| $62.3K | ﹤0.01% |
5,570
-10,628
| -66% | -$100K |
|
6502
LeaderShares Dynamic Yield ETF
DYLD
$40.2M
| $62.3K | ﹤0.01% |
2,775
+2,131
| +331% | +$47.8K |
|
|
CASI
6503
DELISTED
CASI Pharmaceuticals
CASI
| $62.3K | ﹤0.01% |
+11,321
| New | +$35.2K |
|
6504
Arteris
AIP
$1.46B
| $62.2K | ﹤0.01% |
8,283
+6,699
| +423% | +$51K |
|
6505
Red Robin
RRGB
$156M
| $62K | ﹤0.01% |
8,190
-8,006
| -49% | -$58.3K |
|
|
WEA
6506
Western Asset Premier Bond Fund
WEA
$124M
| $62K | ﹤0.01% |
5,907
-4,081
| -41% | -$43.5K |
|
|
KYNB
6507
Kyntra Bio
KYNB
$28.3M
| $61.9K | ﹤0.01% |
2,774
-1,269
| -31% | -$39.2K |
|
6508
Direxion Daily Transportation Bull 3X ETF
TPOR
$18.4M
| $61.8K | ﹤0.01% |
2,081
+2,079
| +103,950% | +$64.2K |
|
6509
Korea Electric Power
KEP
$16B
| $61.7K | ﹤0.01% |
8,707
-292
| -3% | -$2.2K |
|
6510
Genelux
GNLX
$121M
| $61.7K | ﹤0.01% |
31,632
-12,484
| -28% | -$42.4K |
|
6511
Biote Corp
BTMD
$49.4M
| $61.6K | ﹤0.01% |
8,244
-4,756
| -37% | -$29.3K |
|
|
BGMS
6512
Bio Green Med Solution Inc
BGMS
$5.35M
| $61.5K | ﹤0.01% |
158
+138
| +690% | +$66.3K |
|
6513
Inspired Entertainment
INSE
$174M
| $61.5K | ﹤0.01% |
6,721
-14,961
| -69% | -$137K |
|
6514
Forum Energy Technologies
FET
$846M
| $61.5K | ﹤0.01% |
3,647
-6,140
| -63% | -$113K |
|
6515
Pure Cycle
PCYO
$257M
| $61.5K | ﹤0.01% |
6,435
-15,536
| -71% | -$147K |
|
|
CALB
6516
DELISTED
California BanCorp Common Stock
CALB
| $61.4K | ﹤0.01% |
2,857
+1,036
| +57% | +$22.3K |
|
6517
Asure Software
ASUR
$252M
| $61.3K | ﹤0.01% |
7,293
-16,757
| -70% | -$127K |
|
6518
OppFi
OPFI
$833M
| $61.2K | ﹤0.01% |
18,056
+7,279
| +68% | +$22.1K |
|
6519
AMES National
ATLO
$278M
| $61.1K | ﹤0.01% |
2,981
-5,927
| -67% | -$119K |
|
6520
ProKidney
PROK
$337M
| $61K | ﹤0.01% |
24,805
-26,208
| -51% | -$70.4K |
|
6521
Lifeway Foods
LWAY
$475M
| $60.7K | ﹤0.01% |
4,756
+2,972
| +167% | +$54K |
|
|
PPTA
6522
Perpetua Resources
PPTA
$2.86B
| $60.6K | ﹤0.01% |
11,656
-26,387
| -69% | -$157K |
|
6523
Bitdeer Technologies
BTDR
$2.56B
| $60.5K | ﹤0.01% |
5,895
+4,880
| +481% | +$33.5K |
|
6524
Direxion Daily NVDA Bear 1X ETF
NVDD
$18.4M
| $60.4K | ﹤0.01% |
763
+492
| +182% | +$50.7K |
|
6525
Cartesian Therapeutics
RNAC
$265M
| $60.4K | ﹤0.01% |
2,237
-1,677
| -43% | -$40K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.